Cytokinetics | CYTK - Stock


Cytokinetics reported $380K in Stock for its fiscal quarter ending in June of 2026.





Stock Change Date
Acadia Pharmaceuticals USD 108.67M 77.1M Jun/2026
Amgen USD 6.22B 34M Jun/2026
Bayer EUR 12.01B 321M Mar/2026
Biogen USD 2.38B 435.3M Jun/2026
Bristol-Myers Squibb USD 2.74B 19M Jun/2026
Cytokinetics USD 380K 226K Jun/2026
Eisai JPY 257.55B 21.09B Mar/2026
Eli Lilly USD 16.79B 2.26B Jun/2026
Exelixis USD 26.6M 4.92M Mar/2026
Geron USD 123.6M 9.68M Jun/2026
Halozyme Therapeutics USD 137.14M 18.33M Jun/2026
Ionis Pharmaceuticals USD 50.83M 45.28M Jun/2026
Ligand Pharmaceuticals USD 10.26M 3M Jun/2026
Merck USD 6.21B 272M Jun/2026
Novartis USD 6.22B 66M Jun/2026
Pfizer USD 9.94B 722M Jun/2026
Regeneron Pharmaceuticals USD 3.08B 19.3M Jun/2026
Roche Holding CHF 7.6B 9M Jun/2025
Sanofi EUR 24.12B 620M Jun/2026